138 related articles for article (PubMed ID: 23907158)
1. Hot and toxic: hyperthermia and anti-mitotic drugs in cancer therapy.
Barlev NA
Cell Cycle; 2013 Aug; 12(16):2533. PubMed ID: 23907158
[No Abstract] [Full Text] [Related]
2. Targeting mitotic exit with hyperthermia or APC/C inhibition to increase paclitaxel efficacy.
Giovinazzi S; Bellapu D; Morozov VM; Ishov AM
Cell Cycle; 2013 Aug; 12(16):2598-607. PubMed ID: 23907120
[TBL] [Abstract][Full Text] [Related]
3. Blocking Mitotic Exit of Ovarian Cancer Cells by Pharmaceutical Inhibition of the Anaphase-Promoting Complex Reduces Chromosomal Instability.
Raab M; Sanhaji M; Zhou S; Rödel F; El-Balat A; Becker S; Strebhardt K
Neoplasia; 2019 Apr; 21(4):363-375. PubMed ID: 30851646
[TBL] [Abstract][Full Text] [Related]
4. Boosting the apoptotic response of high-grade serous ovarian cancers with CCNE1 amplification to paclitaxel in vitro by targeting APC/C and the pro-survival protein MCL-1.
Raab M; Kobayashi NF; Becker S; Kurunci-Csacsko E; Krämer A; Strebhardt K; Sanhaji M
Int J Cancer; 2020 Feb; 146(4):1086-1098. PubMed ID: 31286496
[TBL] [Abstract][Full Text] [Related]
5. The anaphase-promoting complex: A key mitotic regulator associated with somatic mutations occurring in cancer.
Melloy PG
Genes Chromosomes Cancer; 2020 Mar; 59(3):189-202. PubMed ID: 31652364
[TBL] [Abstract][Full Text] [Related]
6. Peptide inhibitors of the anaphase promoting-complex that cause sensitivity to microtubule poison.
Schuyler SC; Wu YO; Chen HY; Ding YS; Lin CJ; Chu YT; Chen TC; Liao L; Tsai WW; Huang A; Wang LI; Liao TW; Jhuo JH; Cheng V
PLoS One; 2018; 13(6):e0198930. PubMed ID: 29883473
[TBL] [Abstract][Full Text] [Related]
7. Nocodazole-Induced Expression and Phosphorylation of Anillin and Other Mitotic Proteins Are Decreased in DNA-Dependent Protein Kinase Catalytic Subunit-Deficient Cells and Rescued by Inhibition of the Anaphase-Promoting Complex/Cyclosome with proTAME but Not Apcin.
Douglas P; Ye R; Radhamani S; Cobban A; Jenkins NP; Bartlett E; Roveredo J; Kettenbach AN; Lees-Miller SP
Mol Cell Biol; 2020 Jun; 40(13):. PubMed ID: 32284347
[TBL] [Abstract][Full Text] [Related]
8. Spatiotemporal regulation of the anaphase-promoting complex in mitosis.
Sivakumar S; Gorbsky GJ
Nat Rev Mol Cell Biol; 2015 Feb; 16(2):82-94. PubMed ID: 25604195
[TBL] [Abstract][Full Text] [Related]
9. Magnetic nanoparticles for amalgamation of magnetic hyperthermia and chemotherapy: An approach towards enhanced attenuation of tumor.
Singh A; Jain S; Sahoo SK
Mater Sci Eng C Mater Biol Appl; 2020 May; 110():110695. PubMed ID: 32204010
[TBL] [Abstract][Full Text] [Related]
10. The Anaphase Promoting Complex/Cyclosome (APC/C): A Versatile E3 Ubiquitin Ligase.
Curtis NL; Bolanos-Garcia VM
Subcell Biochem; 2019; 93():539-623. PubMed ID: 31939164
[TBL] [Abstract][Full Text] [Related]
11. Suppression of microtubule dynamics by epothilone B is associated with mitotic arrest.
Kamath K; Jordan MA
Cancer Res; 2003 Sep; 63(18):6026-31. PubMed ID: 14522931
[TBL] [Abstract][Full Text] [Related]
12. Alterations of anaphase-promoting complex genes in human colon cancer cells.
Wang Q; Moyret-Lalle C; Couzon F; Surbiguet-Clippe C; Saurin JC; Lorca T; Navarro C; Puisieux A
Oncogene; 2003 Mar; 22(10):1486-90. PubMed ID: 12629511
[TBL] [Abstract][Full Text] [Related]
13. Purification of the mitotic checkpoint complex, an inhibitor of the APC/C from HeLa cells.
Sudakin V; Yen TJ
Methods Mol Biol; 2004; 281():199-212. PubMed ID: 15220531
[TBL] [Abstract][Full Text] [Related]
14. Interactions between hyperthermia and cytotoxic drugs.
Hildebrandt B; Wust P
Cancer Treat Res; 2007; 134():185-93. PubMed ID: 17633054
[TBL] [Abstract][Full Text] [Related]
15. Targeting mitotic exit for cancer treatment.
Wäsch R
Expert Opin Ther Targets; 2011 Jul; 15(7):785-8. PubMed ID: 21476883
[TBL] [Abstract][Full Text] [Related]
16. Affinity purification of mitotic anaphase-promoting complex/cyclosome on p13Suc1.
Hershko A
Methods Enzymol; 2005; 398():170-5. PubMed ID: 16275328
[TBL] [Abstract][Full Text] [Related]
17. Is inflammatory micronucleation the key to a successful anti-mitotic cancer drug?
Mitchison TJ; Pineda J; Shi J; Florian S
Open Biol; 2017 Nov; 7(11):. PubMed ID: 29142107
[TBL] [Abstract][Full Text] [Related]
18. [Mitosis under control].
Castro A; Vigneron S; Lorca T; Labbé JC
Med Sci (Paris); 2003 Mar; 19(3):309-17. PubMed ID: 12836413
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells.
Lub S; Maes A; Maes K; De Veirman K; De Bruyne E; Menu E; Fostier K; Kassambara A; Moreaux J; Hose D; Leleu X; King RW; Vanderkerken K; Van Valckenborgh E
Oncotarget; 2016 Jan; 7(4):4062-76. PubMed ID: 26716651
[TBL] [Abstract][Full Text] [Related]
20. Subunits and substrates of the anaphase-promoting complex.
Peters JM
Exp Cell Res; 1999 May; 248(2):339-49. PubMed ID: 10222126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
